Progesterone: Therapeutic opportunities for neuroprotection and myelin repair
Open accessThe DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Abstract
Progesterone and its metabolites promote the viability of neurons in the brain and spinal cord. Their neuroprotective effects have been documented in different lesion models, including traumatic brain injury (TBI), experimentally induced ischemia, spinal cord lesions and a genetic model of motoneuron disease. Progesterone plays an important role in developmental myelination and in myelin repair, and the aging nervous system appears to remain sensitive to some of progesterone's beneficial effects. Thus, the hormone may promote neuroregeneration by several different actions by reducing inflammation, swelling and apoptosis, thereby increasing the survival of neurons, and by promoting the formation of new myelin sheaths. Recognition of the important pleiotropic effects of progesterone opens novel perspectives for the treatment of brain lesions and diseases of the nervous system. Over the last decade, there have been a growing number of studies showing that exogenous administration of progesterone or some of its metabolites can be successfully used to treat traumatic brain and spinal cord injury, as well as ischemic stroke. Progesterone can also be synthesized by neurons and by glial cells within the nervous system. This finding opens the way for a promising therapeutic strategy, the use of pharmacological agents, such as ligands of the translocator protein (18 kDa) (TSPO; the former peripheral benzodiazepine receptor or PBR), to locally increase the synthesis of steroids with neuroprotective and neuroregenerative properties. A concept is emerging that progesterone may exert different actions and use different signaling mechanisms in normal and injured neural tissue.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Writing Group for the Women's Health Initiative Investigators (2002) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.288.3.321 · Cited by 15,889
Sapolsky, R. M., Romero, L. M., & Munck, A. U. (2000) · Endocrine Reviews · doi:10.1210/edrv.21.1.0389 · Cited by 7,541 · cited 1×
“It may provide an adaptive response to stress and to injury if limited in time but prolonged exposure to elevated levels of glucocorticoids can become damaging for the brain (Sapolsky et al., 2000; McEwen, 2002).”
Sapolsky, R. M. (2000) · Endocrine Reviews · doi:10.1210/er.21.1.55 · Cited by 7,533
Protective and Damaging Effects of Stress Mediators
McEwen, B. S. (1998) · New England Journal of Medicine · doi:10.1056/nejm199801153380307 · Cited by 6,733 · cited 1×
“…prolonged reduced or prolonged elevated levels of glucocorticoids may result in neuron death and in harmful immune responses within the brain, a condition which has been summarized as, “ Too little is like too much ” (McEwen, 1998; De Kloet, 2004; Glezer & Rivest, 2004; Herbert et al., 2006).”
Valery (1995) · doi:10.1001/jama.1995.03520270033028 · Cited by 2,320
Steroid hormone metabolites are barbiturate-like modulators of the GABA receptor
Majewska, M. D., Harrison, N. L., Schwartz, R. D., Barker, J. L., & Paul, S. M. (1986) · Science · doi:10.1126/science.2422758 · Cited by 2,225 · cited 2×
“Most studied have been the potent positive modulation of γ -aminobutyric acid type A (GABA A ) receptors by physiological concentrations of allopregnanolone, the 3 α ,5 α - reduced metabolite of progesterone (3 α ,5 α -tetrahydroproges- terone; Majewska et al., 1986; Belelli et al., 2002).”
Extension of murine life span by overexpression of catalase targeted to mitochondria
Schriner, S. E., Linford, N. J., Martin, G. M., Treuting, P., Ogburn, C. E., Emond, M., Coskun, P. E., Ladiges, W., Wolf, N., Van Remmen, H., et al. (2005) · Science · doi:10.1126/science.1106653 · Cited by 1,724
Combinatorial Control of Gene Expression by Nuclear Receptors and Coregulators
McKenna, N. J., & O'Malley, B. W. (2002) · Cell · doi:10.1016/s0092-8674(02)00641-4 · Cited by 1,463 · cited 1×
“…receptors is continuously increasing, and their cell, promoter-and ligand-specific actions have been extensively reviewed (McKenna et al., 1999; McKenna & O'Malley, 2002; Kalkhoven, 2004; Pearce et al., 2004; Privalsky, 2004; Smith & O'Malley, 2004; Lonard & O'Malley, 2005; Mahajan & Samuels,…”
Gonadal Steroid Induction of Structural Sex Differences in the Central Nervous System
Arnold, A. P., & Gorski, R. A. (1984) · Annual Review of Neuroscience · doi:10.1146/annurev.ne.07.030184.002213 · Cited by 1,198
Nongenomic actions of steroid hormones
Lösel, R., & Wehling, M. (2003) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1009 · Cited by 980 · cited 1×
“Subsequently, homologous proteins were cloned in rat (named 25-Dx), cattle and humans (Lösel & Wehling, 2003).”
Coregulator Function: A Key to Understanding Tissue Specificity of Selective Receptor Modulators
Smith, C. L., & O’Malley, B. W. (2004) · Endocrine Reviews · doi:10.1210/er.2003-0023 · Cited by 931
Endogenous neurosteroids regulate GABAA receptors through two discrete transmembrane sites
Hosie, A. M., Wilkins, M. E., da Silva, H. M. A., & Smart, T. G. (2006) · Nature · doi:10.1038/nature05324 · Cited by 752 · cited 1×
“Allopregnanolone potentiates GABA responses by binding to a cavity located between the transmembrane domains M1 and M4 of α subunits, whereas it directly activates GABA A receptors by binding to interfacial residues between α and β subunits (Hosie et al., 2006).”
Subgroup of reproductive functions of progesterone mediated by progesterone receptor-B isoform
Mulac-Jericevic, B., Mullinax, R. A., DeMayo, F. J., Lydon, J. P., & Conneely, O. M. (2000) · Science · doi:10.1126/science.289.5485.1751 · Cited by 704
Hojo, Y., Hattori, T.-A., Enami, T., Furukawa, A., Suzuki, K., Ishii, H.-T., Mukai, H., Morrison, J. H., Janssen, W. G. M., Kominami, S., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2630225100 · Cited by 644
Molecular biology of the 3β-hydroxysteroid dehydrogenase/Δ5-Δ4 –isomerase gene family
Simard, J., Ricketts, M.-L., Gingras, S., Soucy, P., Feltus, F. A., & Melner, M. H. (2005) · Endocrine Reviews · doi:10.1210/er.2002-0050 · Cited by 620 · cited 2×
“There are multiple isoforms of the 3 β - HSD encoded by different genes (Simard et al., 2005).”
GABAA receptor α4 subunit suppression prevents withdrawal properties of an endogenous steroid
Smith, S. S., Gong, Q. H., Hsu, F.-C., Markowitz, R. S., ffrench-Mullen, J. M. H., & Li, X. (1998) · Nature · doi:10.1038/31948 · Cited by 564 · cited 2×
“These withdrawal properties were attributable to increased expression of the GABA A receptor α 4 subunit (Smith et al., 1998a).”
Nongenomic steroid action: controversies, questions, and answers
LÖSEL, R. M., FALKENSTEIN, E., FEURING, M., SCHULTZ, A., TILLMANN, H.-C., ROSSOL-HASEROTH, K., & WEHLING, M. (2003) · Physiological Reviews · doi:10.1152/physrev.00003.2003 · Cited by 561 · cited 1×
“…its metabolites comprise the regulation of gene transcription, the modulation of neurotransmitter receptors and the activation of signaling cascades via membrane receptors (Mani & O'Malley, 2002; Schumacher & Robert, 2002; Li & O'Malley, 2003; Lösel et al., 2003; Pettus et al., 2005; Mani, 2006).”
Progesterone synthesis and myelin formation by Schwann cells
Koenig, H. L., Schumacher, M., Ferzaz, B., Thi, A. N. D., Ressouches, A., Guennoun, R., Jung-Testas, I., Robel, P., Akwa, Y., & Baulieu, E.-E. (1995) · Science · doi:10.1126/science.7770777 · Cited by 480
Self-citationMonnet, F. P., Mahé, V, Robel, P., & Baulieu, E. E. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.9.3774 · Cited by 429 · cited 1×
“…of the N -methyl- D - aspartate (NMDA) response of hippocampal neurons and the NMDA-evoked norepinephrine release from preloaded hippocampal slices by σ 1 ligands, were both strongly reduced in the presence of progesterone (Monnet et al., 1995; Debonnel et al., 1996; Bergeron et al., 1999).”
PAPADOPOULOS, V. (1993) · Endocrine Reviews · doi:10.1210/edrv-14-2-222 · Cited by 417 · cited 1×
“This represents a rate-limiting step in the biosynthesis of steroids (Papadopoulos, 1993; Papadopoulos et al., 2006b).”
Neurosteroid biosynthesis: genes for adrenal steroidogenic enzymes are expressed in the brain
Mellon, S. H., & Deschepper, C. F. (1993) · Brain Research · doi:10.1016/0006-8993(93)91332-m · Cited by 398
Niemann-Pick type C disease involves disrupted neurosteroidogenesis and responds to allopregnanolone
Griffin, L. D., Gong, W., Verot, L., & Mellon, S. H. (2004) · Nature Medicine · doi:10.1038/nm1073 · Cited by 395
Selective serotonin reuptake inhibitors directly alter activity of neurosteroidogenic enzymes
Griffin, L. D., & Mellon, S. H. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.23.13512 · Cited by 387 · cited 1×
“Sertraline also blocked the reverse oxidative reaction, the conversion of allopregnanolone to 5 α -dihydroprogesterone (Griffin & Mellon, 1999).”
Hall, E. D., Sullivan, P. G., Gibson, T. R., Pavel, K. M., Thompson, B. M., & Scheff, S. W. (2005) · Journal of Neurotrauma · doi:10.1089/neu.2005.22.252 · Cited by 319 · cited 1×
“Thus, sex differences in the outcome of TBI favoring females, consistently observed after diffuse weight-drop-induced TBI, could not be confirmed after more severe focal impact injury, characterized by a very fast evolution of neurodegeneration (Hall et al., 2005a, 2005b).”
Estrogen Increases Mitochondrial Efficiency and Reduces Oxidative Stress in Cerebral Blood Vessels
Stirone, C., Duckles, S. P., Krause, D. N., & Procaccio, V. (2005) · Molecular Pharmacology · doi:10.1124/mol.105.014662 · Cited by 315 · cited 1×
“However, steroids can also exert direct actions on mitochondria, as has been demonstrated for estrogens and glucocorticoids (Chen et al., 2005; Stirone et al., 2005; Duckles et al., 2006; Pedram et al., 2006; Psarra et al., 2006).”
Hormones and the Stressed Brain
DE KLOET, E. R. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1296.001 · Cited by 314 · cited 1×
“…prolonged reduced or prolonged elevated levels of glucocorticoids may result in neuron death and in harmful immune responses within the brain, a condition which has been summarized as, “ Too little is like too much ” (McEwen, 1998; De Kloet, 2004; Glezer & Rivest, 2004; Herbert et al., 2006).”
Lipid peroxidation and oxidative imbalance: early functional events in Alzheimer's disease
Praticò, D., & Sung, S. (2004) · Journal of Alzheimer s Disease · doi:10.3233/jad-2004-6209 · Cited by 229 · cited 2×
“…the oxidation of neuronal lipids resulting from an oxidative imbalance has been proposed to play a significant role in Alzheimer's pathogenesis (Pratico & Sung, 2004), and consequently, as noted above, may represent an interesting therapeutic target for progesterone in the early stages of the…”
Female sex steroids: effects upon microglial cell activation
Drew, P. D., & Chavis, J. A. (2000) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(00)00386-6 · Cited by 209 · cited 1×
“…inflammation by repressing the activation of microglial cells and by inhibiting the production of pro-inflammatory cytokines (Miller & Hunt, 1998; Drew & Chavis, 2000; He et al., 2004; Pettus et al., 2005) and upregulates the expression of neurotrophins, such as BDNF (Gonzalez et al., 2004,…”
Guennoun, R., Fiddes, R. J., Gouézou, M., Lombès, M., & Baulieu, E.-E. (1995) · Molecular Brain Research · doi:10.1016/0169-328x(95)00016-l · Cited by 208
Self-citationAuger, A. P., Tetel, M. J., & McCarthy, M. M. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.13.7551 · Cited by 196 · cited 1×
“Thus, infusion of SRC-1 or CBP antisense oligodeox-ynucleotides into the rat brain impaired the process of steroid-dependent sexual differentiation of brain structures and inhibited progesterone-facilitated sexual receptivity in females (Auger et al., 2000, 2002; Molenda et al., 2002).”
Expanding functional diversity of the coactivators
Lonard, D. M., & O'Malley, B. W. (2005) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2005.01.001 · Cited by 172 · cited 2×
“It should also be emphasized that numerous other coactivator complexes are involved in bridging the RNA polymerase II complex with basal transcription factors (Nishihara et al., 2004; Lonard & O'Malley, 2005).”
Robertson, C. L., Puskar, A., Hoffman, G. E., Murphy, A. Z., Saraswati, M., & Fiskum, G. (2006) · Experimental Neurology · doi:10.1016/j.expneurol.2005.09.014 · Cited by 152 · cited 20×
“Stable elevated progesterone levels were achieved following TBI by the intravenous infusion of the natural hormone for 3 days (Wright et al., 2005).”
InfluentialMarin-Husstege, M., Muggironi, M., Raban, D., Skoff, R. P., & Casaccia-Bonnefil, P. (2004) · Developmental Neuroscience · doi:10.1159/000082141 · Cited by 129
Ferzaz, B., Brault, E., Bourliaud, G., Robert, J.-P., Poughon, G., Claustre, Y., Marguet, F., Liere, P., Schumacher, M., Nowicki, J.-P., et al. (2002) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.301.3.1067 · Cited by 126
Self-citationLiere, P., Pianos, A., Eychenne, B., Cambourg, A., Liu, S., Griffiths, W., Schumacher, M., Sjövall, J., & Baulieu, E.-E. (2004) · Journal of Lipid Research · doi:10.1194/jlr.m400244-jlr200 · Cited by 118 · cited 1×
“Steroid levels were quantified by gas chromatography/mass spectrometry (Liere et al., 2000, 2004).”
Self-citationHansson, A. C., Sommer, W. H., Metsis, M., Strömberg, I., Agnati, L. F., & Fuxe, K. (2006) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2005.01390.x · Cited by 104 · cited 1×
“The expression of brain-derived neurotrophic factor (BDNF) in the CNS is also differentially regulated by progesterone and glucocorticoids: up-regulated by the former and down-regulated by the latter (Chao & McEwen, 1994; Gonzalez et al., 2004; Hansson et al., 2006).”
LI, W., PENDERIS, J., ZHAO, C., SCHUMACHER, M., & FRANKLIN, R. (2006) · Experimental Neurology · doi:10.1016/j.expneurol.2006.05.012 · Cited by 95 · cited 1×
“Interestingly, the extent of oligodendrocyte remyelination was significantly less in the middle-aged males compared with females, pointing to a sex-associated divergence in remyelination efficiency with age (Li et al., 2006).”
Self-citationProgesterone treatment of spinal cord injury: effects on receptors, neurotrophins, and myelination
De Nicola, A. F., Gonzalez, S. L., Labombarda, F., Deniselle, M. C. G., Garay, L., Guennoun, R., & Schumacher, M. (2006) · Journal of Molecular Neuroscience · doi:10.1385/jmn:28:1:3 · Cited by 92 · cited 1×
“This has been demonstrated after spinal cord transection and in the Wobbler mouse (De Nicola et al., 2003; Gonzalez Deniselle et al., 2005; De Nicola et al., 2006).”
Self-citationAuger, A. P., Perrot-Sinal, T. S., Auger, C. J., Ekas, L. A., Tetel, M. J., & McCarthy, M. M. (2002) · Endocrinology · doi:10.1210/en.143.8.3009 · Cited by 89 · cited 1×
“Thus, infusion of SRC-1 or CBP antisense oligodeox-ynucleotides into the rat brain impaired the process of steroid-dependent sexual differentiation of brain structures and inhibited progesterone-facilitated sexual receptivity in females (Auger et al., 2000, 2002; Molenda et al., 2002).”
Lee, T. C., Miller, W. L., & Auchus, R. J. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.6.5646 · Cited by 71
The ontogeny of gene expression of progestin receptors in the female rat brain
Kato, J., Hirata, S., Nozawa, A., & Mouri, N. (1993) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/0960-0760(93)90072-5 · Cited by 68
Cloning and expression of a novel, truncated, progesterone receptor
Saner, K. J., Welter, B. H., Zhang, F., Hansen, E., Dupont, B., Wei, Y., & Price, T. M. (2003) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(02)00380-5 · Cited by 64
Role of the peripheral benzodiazepine receptor in sensory neuron regeneration
Mills, C. D., Bitler, J. L., & Woolf, C. J. (2005) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2005.07.010 · Cited by 42
Auchus, R. J., Sampath Kumar, A., Andrew Boswell, C., Gupta, M. K., Bruce, K., Rath, N. P., & Covey, D. F. (2003) · Archives of Biochemistry and Biophysics · doi:10.1016/s0003-9861(02)00491-5 · Cited by 39 · cited 1×
“A previous study showed that ent -progesterone is a potent competitive inhibitor of the cytochromes P450c17 and P450c21, human enzymes involved in steroid metabolism (Auchus et al., 2003).”
Cited by
Progesterone receptors: form and function in brain
Brinton, R. D., Thompson, R. F., Foy, M. R., Baudry, M., Wang, J., Finch, C. E., Morgan, T. E., Pike, C. J., Mack, W. J., Stanczyk, F. Z., et al. (2008) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2008.02.001 · Cited by 675
Adibhatla, R. M., & Hatcher, J. F. (2010) · Antioxidants & Redox Signaling · doi:10.1089/ars.2009.2668 · Cited by 480
Traumatic Brain Injury: An Overview of Pathobiology with Emphasis on Military Populations
Cernak, I., & Noble-Haeusslein, L. J. (2010) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2009.203 · Cited by 444
Do Rego, J. L., Seong, J. Y., Burel, D., Leprince, J., Luu-The, V., Tsutsui, K., Tonon, M.-C., Pelletier, G., & Vaudry, H. (2009) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2009.05.006 · Cited by 357
Schumacher, M., Mattern, C., Ghoumari, A., Oudinet, J. P., Liere, P., Labombarda, F., Sitruk-Ware, R., De Nicola, A. F., & Guennoun, R. (2014) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2013.09.004 · Cited by 355
Self-citation
Metadata
- Authors
- Schumacher, M., Guennoun, R., Stein, D. G., & De Nicola, A. F.
- Venue
- Pharmacology & Therapeutics
- Publisher
- Elsevier BV
- Published
- 2007-10
- Volume
- 116
- Issue
- 1
- Pages
- 77-106
- ISSN
- 0163-7258 (ISSN-L)
- OpenAlex
- W2005884759
- Cited by
- 246
- References
- 44
- FWCI
- 15.97
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.